PARADEEP Paradeep Phosphates Q2 FY25 results (Jul–Sep 2024) and concall
Paradeep Phosphates delivered a strong Q2 FY25 performance characterized by significant margin expansion and robust volume growth across its NPK portfolio. The company is aggressively pursuing 100% backward integration for phosphoric acid through a new ₹250 crore CAPEX plan, aiming to reduce import dependency. Management highlighted a strategic shift away from DAP towards value-added products and successful market share gains in Northern India, supported by a strengthening balance sheet.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 |
|---|---|
| Revenue | 4,619 |
| EBITDA | 507 |
| Net profit | 255 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
